CME Group Inc. CME
$307.56
+0.41%
at last close
Analyst Consensus
- Consensus Rating
- Moderate Buy (8 Buy · 5 Hold · 1 Sell)
- Average Price Target
- $313.08
- Implied Upside
- +1.8%
- Price Target Range
- $230.00 – $367.00
- Analysts (12 mo)
- 14
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-10-22 | UBSAlex Kramm |
Maintains | Neutral | $270 → $310 |
| 2026-10-22 | Morgan StanleyMichael Cyprys |
Maintains | Overweight | $337 → $359 |
| 2026-10-22 | BarclaysBenjamin Budish |
Maintains | Equal-weight | $281 → $321 |
| 2026-10-22 | Wells FargoDaniel Welden |
Maintains | Overweight | $315 → $333 |
| 2026-10-22 | Piper SandlerPatrick Moley |
Reiterates | Overweight | $295 → $330 |
| 2026-10-22 | JP MorganKenneth Worthington |
Upgrades | Underweight → Overweight | $367 |
| 2026-10-14 | Wells FargoDaniel Welden |
Maintains | Overweight | $301 → $315 |
| 2026-10-09 | Morgan StanleyMichael Cyprys |
Maintains | Overweight | $330 → $337 |
| 2026-10-07 | BarclaysBenjamin Budish |
Maintains | Equal-weight | $270 → $281 |
| 2026-10-05 | UBSAlex Kramm |
Maintains | Neutral | $260 → $270 |
| 2026-10-05 | TD CowenBill Katz |
Maintains | Buy | $292 → $300 |
| 2026-10-02 | Wells FargoDaniel Welden |
Initiates coverage on | Overweight | $301 |
| 2026-09-28 | TD CowenBill Katz |
Reiterates | Buy | $292 |
| 2026-09-03 | TD CowenBill Katz |
Reiterates | Buy | $292 |
| 2026-08-19 | Deutsche BankBrian Bedell |
Downgrades | Buy → Hold | $286 → $270 |
| 2026-07-23 | JP MorganKenneth Worthington |
Maintains | Underweight | $249 → $250 |
| 2026-07-23 | B of A SecuritiesCraig Siegenthaler |
Maintains | Underperform | $226 → $230 |
| 2026-07-23 | Morgan StanleyMichael Cyprys |
Maintains | Overweight | $324 → $330 |
| 2026-07-15 | Piper SandlerPatrick Moley |
Maintains | Overweight | $329 → $295 |
| 2026-07-10 | Morgan StanleyMichael Cyprys |
Maintains | Overweight | $353 → $324 |
| 2026-07-09 | BarclaysBenjamin Budish |
Maintains | Equal-weight | $316 → $270 |
| 2026-07-08 | TD CowenBill Katz |
Maintains | Buy | $273 → $270 |
| 2026-07-06 | UBSAlex Kramm |
Maintains | Neutral | $310 → $260 |
| 2026-07-02 | Raymond JamesPatrick O'Shaughnessy |
Reiterates | Outperform | $320 |
| 2026-06-18 | Keefe, Bruyette & WoodsChris Allen |
Upgrades | Market perform → Outperform | $305 |
| 2026-06-11 | Rothschild & CoSimon Clinch |
Upgrades | Neutral → Buy | $316 → $323 |
| 2026-04-23 | Morgan StanleyMichael Cyprys |
Maintains | Overweight | $362 → $353 |
| 2026-04-23 | BarclaysBenjamin Budish |
Maintains | Equal-weight | $343 → $316 |
| 2026-04-15 | Piper SandlerPatrick Moley |
Maintains | Overweight | $313 → $329 |
| 2026-04-13 | BarclaysBenjamin Budish |
Maintains | Equal-weight | $344 → $343 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $307.56
- Market Cap
- $109.64 billion
- 52-Week Range
- $218.31 – $329.16
- Average Volume
- 2.05 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.
